|

MET233 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Metsera, a wholly owned subsidiary of Pfizer1

Indications

  • Obesity and Obesity-related Medical Conditions1
  • Diabetes1

Cypress, California1 trial

A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

Research Site MET233/097 24-101-001

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.